MOH
- Status: likely_approved
🇮🇱 Gleevec in Israel
Gleevec (imatinib) regulatory status in Israel.
Marketing authorisations
MOH
- Status: likely_approved
MOH
- Status: likely_approved
MOH
- Status: likely_approved
MOH
- Status: likely_approved
MOH
- Status: likely_approved
Gleevec in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Oncology approved in Israel
Frequently asked questions
Is Gleevec approved in Israel?
Yes. MOH has authorised it; MOH has authorised it; MOH has authorised it.
Who is the marketing authorisation holder for Gleevec in Israel?
Novartis is the originator. The local marketing authorisation holder may differ — check the official source linked above.